Blood Screening Market Overview Analysis, Growth Values, Demand Prospects, Future Trends, Key Company Profiles, Business Opportunities and Forecast to 2026
A blood screening is a process of testing blood which is done prior to blood transfusion to ensure that recipients receive safe blood products. Blood samples collected during donation undergo laboratory screening for Transfusion-Transmissible Infections (TTIs) in order to detect infectious disease pathogens such as hepatitis B and C viruses and human immunodeficiency virus (HIV). Immunoassays (IAs) and nucleic acid amplification technology (NAT) assays are two major type of blood screening tests. Immunoassays (IAs) are further subcategorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays, and rapid/simple single-use assays (rapid tests).
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2409
Rising demand for NAT over ELISA (enzyme-linked immunosorbent assay) test owing to high sensitivity and specificity for viral nucleic acid is propelling the blood screening market growth. For instance, in 2018, Grifols received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays- Procleix Ultrio Elite and Procleix WNV. Both assays run on the fully automated NAT blood screening platform: Procleix Panther system. The Procleix Panther system with these assays helps blood centers to efficiently screen for infectious diseases and eliminates the need for batch processing.
A growing number of blood donation campaigns by the government such as blood donor agencies, and NGO’s are further expected to propel the growth of the blood screening market. For instance, according to the WHO reported data in June 2017, around 112.5 million blood donations are collected globally and around half of these are collected in high-income countries, highlighting 19% of the world’s population. Moreover, rising initiatives by the government to spread awareness among the people regarding the safety of blood donation is expected to drive the growth of the market. For instance, in 2014, World Health Organization (WHO) recommended to establish a national blood system with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation that can provide sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2409
On the other hand, shortages of trained staff and poor quality systems are expected to restrain the growth of the market.
On the basis of region, the global blood screening market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Geographically, North America is expected to dominate the blood screening market, and this can be attributed to the rising number of acquisitions by major players in the region. For Instance, in July 2017, Grifols acquired the NAT (Nucleic Acid Testing) donor screening unit from the U.S. Company Hologic for a purchase price of US$ 1,850 Million. This agreement bound to research, development, and manufacture of assays and instrument activities by using NAT technology that allows detection of infectious agents present in blood and plasma donations, contributing to greater transfusion safety.
The Asia Pacific is projected to witness significant growth in the blood screening market and this can be attributed to increasing government initiatives and rising awareness regarding the transmission of diseases during blood transfusion among the population. For instance, in June 2015, a National Blood Donor Vigilance Programme (NBDVP) was launched in India on the World Blood Donor Day. The objectives of the NBDVP is to increase blood donation frequency and reduce the frequency of the adverse event and to analyze the risk factor and evaluate preventive measure.
Key Player operating in the blood screening market include Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary of Danaher Corporation) and Becton, Dickinson, and Company.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/blood-screening-market-2409
- Nucleic acid amplification technology (NAT)
- Immunoassays (IAs)
- Next-Generation Sequencing (NGS)
- Western Blotting
By Product Type
- Reagents & Kits
By End User:
- Blood Banks
- Diagnostics Laboratory
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire